GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (XCNQ:MVMD) » Definitions » EPS (Diluted)

Mountain Valley MD Holdings (XCNQ:MVMD) EPS (Diluted) : C$-0.01 (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings EPS (Diluted)?

Mountain Valley MD Holdings's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was C$-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.01.

Mountain Valley MD Holdings's EPS (Basic) for the three months ended in Sep. 2024 was C$-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.01.

Mountain Valley MD Holdings's EPS without NRI for the three months ended in Sep. 2024 was C$-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 35.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Mountain Valley MD Holdings's highest 3-Year average EPS without NRI Growth Rate was 35.90% per year. The lowest was 35.90% per year. And the median was 35.90% per year.


Mountain Valley MD Holdings EPS (Diluted) Historical Data

The historical data trend for Mountain Valley MD Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings EPS (Diluted) Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
EPS (Diluted)
-0.09 -0.03 -0.03 -0.02 -0.02

Mountain Valley MD Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - - -

Competitive Comparison of Mountain Valley MD Holdings's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Valley MD Holdings's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Mountain Valley MD Holdings's PE Ratio falls into.



Mountain Valley MD Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Mountain Valley MD Holdings's Diluted EPS for the fiscal year that ended in Mar. 2024 is calculated as

Diluted EPS (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.67-0)/329.653
=-0.02

Mountain Valley MD Holdings's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.568-0)/352.355
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings  (XCNQ:MVMD) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Mountain Valley MD Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Valley MD Holdings Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.
Executives
Azhar Ali Khan Rana Senior Officer
Nancy Richardson Director
Kevin Terry Wayne Puloski Director

Mountain Valley MD Holdings Headlines

No Headlines